Tag Archives: Memantine Hydrochloride

Statistics on Prescriptions Dispensed in the Community Between 2005 and 2015 (BBC News / HSCIC)

Summary A Health and Social Care Information Centre (HSCIC) statistical summary of the prescriptions dispensed by community pharmacists, appliance contractors and dispensing doctors in England indicates significant trends between 2005 and 2015. Prescriptions for antidepressants (costing the NHS £780,000 per … Continue reading

Posted in BBC News, Community Care, Depression, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, National, NHS, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

NHS RightCare’s Mental Health and Dementia Commissioning for Value Focus Packs (NHS England / NHS RightCare)

NHS Right Care has released a further three sets of “Commissioning for Value” packs to help CCGs identify opportunities for improving resource allocation and value when designing services for local communities. These Mental Health and Dementia, Cancer and Tumours, and Musculoskeletal (Trauma … Continue reading

Posted in Acute Hospitals, Commissioning, Community Care, Depression, Diagnosis, End of Life Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Pharmacological Treatments for Alzheimer’s Disease in Primary Care / Management of Cognitive Symptoms (DTB / Nursing Times)

Summary A Drug and Therapeutics Bulletin (DTB) article reviews the evidence concerning drugs prescribed for cognitive symptoms in Alzheimer’s Disease and discusses some issues in their prescription. Donepezil, galantamine and rivastigmine are licensed for mild to moderate Alzheimer’s Disease in … Continue reading

Posted in Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Management of Condition, Models of Dementia Care, NICE Guidelines, Pharmacological Treatments, Practical Advice, Quick Insights, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Combination Therapy with Cholinesterase Inhibitors and Memantine (Dementia and Geriatric Cognitive Disorders Extra)

Summary This systematic review investigates the efficacy and safety of combination therapy with N-methyl-D-aspartic acid antagonists (memantine) and cholinesterase inhibitors (ChEIs) for treatment of dementia, compared to monotherapy with either memantine or a ChEI. Combination therapy appears to offer statistically … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), International, Pharmacological Treatments, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , | Leave a comment

Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (Health Technology Assessment)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 11, June 2012]. Summary The purpose of this Health Technology Assessment was to review and update guidance to the NHS in England and Wales … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NHS, NIHR, Pharmacological Treatments, Proposed for Next Newsletter, Systematic Reviews, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Update to Dementia on Clinical Knowledge Summaries (Prodigy, formerly CKS)

Summary The Prodigy (formerly Clinical Knowledge Summaries, CKS) topic on Dementia has been updated to include prescribing information for Memantine (Memantine Hydrochloride). Sub-topics comprise: Contraindications. Dose and Titration. Adverse Effects. Drug Interactions. The Basis of Recommendation has been updated to … Continue reading

Posted in For Doctors (mostly), Guidelines, Management of Condition, National, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, UK | Tagged , , , , , , , , , , , | Leave a comment

Alzheimer’s Disease: Medicines (NHS Choices)

Summary This NHS Choices web page gives access to overviews of medicines prescribed in the UK for Alzheimer’s Disease. The drugs for which links to information are provided here include: Aricept. Ebixa (a brand of memantine hydrochloride). Exelon. Galantamine hydrobromide. Memantine hydrochloride. Reminyl (a brand … Continue reading

Posted in For Carers (mostly), For Nurses and Therapists (mostly), NHS, NHS Digital (Previously NHS Choices), Patient Information, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged , , , , , , , , | Leave a comment